| scholarly article | Q13442814 |
| P2093 | author name string | Tianfu Li | |
| Detlev Boison | |||
| Roger P Simon | |||
| Bertil B Fredholm | |||
| Jing Quan Lan | |||
| P2860 | cites work | Purinergic signalling in neuron-glia interactions | Q24684324 |
| The equilibrative nucleoside transporter family, SLC29 | Q28184224 | ||
| The concentrative nucleoside transporter family, SLC28 | Q28186657 | ||
| International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors | Q28209239 | ||
| Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy | Q28366761 | ||
| Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis | Q28585948 | ||
| Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate | Q29620128 | ||
| Modulation of neuronal excitability by astrocytes | Q33748460 | ||
| Adenosine and suppression of seizures | Q33748604 | ||
| Activities and some properties of 5′-nucleotidase, adenosine kinase and adenosine deaminase in tissues from vertebrates and invertebrates in relation to the control of the concentration and the physiological role of adenosine | Q33879557 | ||
| Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor | Q33931315 | ||
| Fine-tuning neuromodulation by adenosine | Q34023335 | ||
| Neonatal hepatic steatosis by disruption of the adenosine kinase gene | Q34068093 | ||
| Extracellular metabolism of ATP and other nucleotides | Q34101805 | ||
| The role and regulation of adenosine in the central nervous system | Q34205330 | ||
| Adenosine A1 receptors are crucial in keeping an epileptic focus localized | Q48512398 | ||
| The anticonvulsive action of adenosine: a postsynaptic, dendritic action by a possible endogenous anticonvulsant | Q48612210 | ||
| Loss of A1 adenosine receptors in human temporal lobe epilepsy | Q49110833 | ||
| Adenosine and seizure termination | Q67924737 | ||
| Sedative and anticonvulsant effects of adenosine analogs in mouse and rat | Q70264259 | ||
| Endogenously released adenosine regulates excitability in the in vitro hippocampus | Q71329694 | ||
| Kinetic studies of rat liver adenosine kinase. Explanation of exchange reaction between adenosine and AMP | Q72050247 | ||
| Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: a quantitative autoradiographic study | Q72744091 | ||
| Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial | Q79916626 | ||
| Is adenosine an endogenous anticonvulsant? | Q93614424 | ||
| Astrocytic purinergic signaling coordinates synaptic networks | Q34457580 | ||
| Adenosine kinase, epilepsy and stroke: mechanisms and therapies | Q34575897 | ||
| The role of mitochondria in epileptogenesis | Q34581931 | ||
| The tripartite synapse: roles for gliotransmission in health and disease | Q34598804 | ||
| Cell and gene therapies in epilepsy--promising avenues or blind alleys? | Q34737233 | ||
| Adenosine and brain function | Q36083482 | ||
| Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs | Q36094581 | ||
| Epilepsy and apoptosis pathways | Q36124552 | ||
| Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control. | Q36391066 | ||
| The adenosine kinase hypothesis of epileptogenesis | Q36515651 | ||
| Astrocyte control of synaptic transmission and neurovascular coupling. | Q36525563 | ||
| Concise review: prospects of stem cell therapy for temporal lobe epilepsy. | Q36729233 | ||
| Adenosine-based cell therapy approaches for pharmacoresistant epilepsies. | Q36788952 | ||
| Etiology and management of refractory epilepsies | Q36840599 | ||
| Cell therapy in models for temporal lobe epilepsy | Q36848783 | ||
| Pharmacotherapy of epilepsy: new armamentarium, new issues | Q36873342 | ||
| Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity | Q36896736 | ||
| Adenosine as a neuromodulator in neurological diseases | Q36974004 | ||
| Adenosine as a modulator of brain activity. | Q37095277 | ||
| Cell and gene therapies for refractory epilepsy. | Q37211817 | ||
| Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy | Q37221596 | ||
| Evidence for a substrate cycle between AMP and adenosine in isolated hepatocytes | Q37611315 | ||
| Adenosine: a potential mediator of seizure arrest and postictal refractoriness | Q41102217 | ||
| Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice | Q41862804 | ||
| An astrocytic basis of epilepsy | Q42218578 | ||
| Transgenic overexpression of adenosine kinase aggravates cell death in ischemia. | Q42495104 | ||
| Increase in adenosine metabolites in human cerebrospinal fluid after status epilepticus | Q42714430 | ||
| Calcium oscillations in neocortical astrocytes under epileptiform conditions | Q43827076 | ||
| Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy | Q44489270 | ||
| Engineering embryonic stem cell derived glia for adenosine delivery | Q45109679 | ||
| Correlations between granule cell physiology and bioenergetics in human temporal lobe epilepsy | Q45280959 | ||
| Regional energetic dysfunction in hippocampal epilepsy. | Q45289906 | ||
| Seizure suppression and lack of adenosine A1 receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts | Q45882674 | ||
| Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation | Q46522369 | ||
| Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury | Q46668123 | ||
| Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs | Q46898809 | ||
| Dorsal telencephalon-specific expression of Cre recombinase in PAC transgenic mice. | Q47867280 | ||
| Suppression of kindling epileptogenesis by adenosine releasing stem cell-derived brain implants. | Q48181919 | ||
| Downregulation of hippocampal adenosine kinase after focal ischemia as potential endogenous neuroprotective mechanism. | Q48189464 | ||
| Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans. | Q48415054 | ||
| Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme. | Q48465634 | ||
| P433 | issue | 4 | |
| P921 | main subject | seizure | Q6279182 |
| P304 | page(s) | 353-366 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Neuron Glia Biology | Q15755054 |
| P1476 | title | Adenosine dysfunction in astrogliosis: cause for seizure generation? | |
| P478 | volume | 3 |
| Q43244027 | Adenosine and seizure termination: endogenous mechanisms |
| Q30466024 | Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia. |
| Q37269991 | Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies. |
| Q34073789 | Adenosine dysfunction and adenosine kinase in epileptogenesis |
| Q36036212 | Adenosine dysfunction in epilepsy |
| Q30457808 | Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy |
| Q34788009 | Adenosine kinase as a target for therapeutic antisense strategies in epilepsy |
| Q26852056 | Adenosine kinase: exploitation for therapeutic gain |
| Q24634273 | Adenosine signaling and function in glial cells |
| Q36643060 | Adenosinergic signaling in epilepsy |
| Q33941456 | Altered thermoregulation via sensitization of A1 adenosine receptors in dietary-restricted rats. |
| Q42920673 | Anticonvulsant action of 2-chloroadenosine against pentetrazol-induced seizures in immature rats is due to activation of A1 adenosine receptors |
| Q28534300 | Anticonvulsant activity of B2, an adenosine analog, on chemical convulsant-induced seizures |
| Q37310106 | Antiepileptic effects of silk-polymer based adenosine release in kindled rats. |
| Q34617250 | Apoptosis, Bcl-2 family proteins and caspases: the ABCs of seizure-damage and epileptogenesis? |
| Q34193177 | Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery. |
| Q47653416 | Commonalities in epileptogenic processes from different acute brain insults: Do they translate? |
| Q35956389 | Comorbidities in Neurology: Is adenosine the common link? |
| Q62868133 | Epilepsy |
| Q90473578 | General Pathophysiology of Astroglia |
| Q36912637 | Glial adenosine kinase--a neuropathological marker of the epileptic brain |
| Q42513030 | Homeostatic control of synaptic activity by endogenous adenosine is mediated by adenosine kinase. |
| Q42558822 | Human mesenchymal stem cell grafts engineered to release adenosine reduce chronic seizures in a mouse model of CA3-selective epileptogenesis |
| Q34126428 | Inhibitory RNA in epilepsy: research tools and therapeutic perspectives |
| Q34701303 | International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update |
| Q30476169 | Manipulation of adenosine kinase affects sleep regulation in mice |
| Q34154555 | Methylxanthines, seizures, and excitotoxicity. |
| Q34842250 | Modulators of nucleoside metabolism in the therapy of brain diseases. |
| Q35924978 | Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity |
| Q48197598 | Neuroprotective Effects of the Absence of JNK1 or JNK3 Isoforms on Kainic Acid-Induced Temporal Lobe Epilepsy-Like Symptoms |
| Q27329978 | Nonsynaptic Communication Through ATP Release from Volume-Activated Anion Channels in Axons |
| Q36476253 | Opiate-induced changes in brain adenosine levels and narcotic drug responses |
| Q37619427 | Overexpression of adenosine kinase in cortical astrocytes and focal neocortical epilepsy in mice |
| Q35624347 | Purines and neuronal excitability: links to the ketogenic diet |
| Q38154412 | Research advances in basic mechanisms of seizures and antiepileptic drug action |
| Q64100680 | Role of DNA Methylation and Adenosine in Ketogenic Diet for Pharmacoresistant Epilepsy: Focus on Epileptogenesis and Associated Comorbidities |
| Q34617266 | Seizure preconditioning and epileptic tolerance: models and mechanisms |
| Q38121340 | Sudden unexpected death in Dravet syndrome: respiratory and other physiological dysfunctions |
| Q26752724 | The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine |
| Q90622685 | The role of adenosine A1 receptor agonist in adenosine augmentation therapy for patients with refractory epilepsy in Sturge-Weber syndrome: An in vitro electrophysiological study |
| Q36090119 | The role of astroglia in the epileptic brain. |
| Q34997511 | Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation |
| Q46601743 | Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy. |
| Q91993954 | Transient use of a systemic adenosine kinase inhibitor attenuates epilepsy development in mice |
| Q38589482 | Translational potential of astrocytes in brain disorders |
| Q34606639 | Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice |
| Q37272771 | Upregulation of adenosine kinase in Rasmussen encephalitis |
Search more.